PeterMD vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

Willow beats PeterMD overall, scoring 7.5/10 vs 7.3/10. PeterMD is more affordable at $165/mo vs $299/mo. Choose PeterMD for budget-conscious users looking for the lowest monthly glp-1 . Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side look at PeterMD and Willow to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

PeterMD

#32 of 52

7.3/10

One of the most affordable compounded GLP-1 options on the market, ideal for budget-conscious patients.

Visit PeterMD

Higher Rated

Willow

#24 of 52

7.5/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	PeterMD	Willow
Our Score	7.3/10	7.5/10
Starting Price	$165/mo	$299/mo
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Budget-conscious users looking for the lowest monthly GLP-1 cost	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking	#32	#24
Get started	Visit PeterMD	Visit Willow

Pros & Cons Compared

PeterMD

Pros

+Flat $165/mo at all dose levels, price doesn't increase as you titrate up to maintenance doses
+100,000+ patient base with 4.9/5 Trustpilot rating from 14,000+ reviews, strong social proof
+Semaglutide + B12 formulation helps reduce nausea, the most common GLP-1 side effect
+Video consultations with physicians included, real face-to-face medical oversight

Cons

−Available in 42 states, not all 50 (8 states are excluded). Check your state during signup before planning around PeterMD.
−Not BBB accredited, and some documented complaints cite delayed medication fulfillment. Order refills ahead of your last dose rather than at the last minute.
−PeterMD began as a testosterone replacement therapy platform; GLP-1 is an expansion, not the original core. The included video consultations give you a direct read on the clinical team.

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only, no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
−Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024, less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out PeterMD with a score of 7.5/10 vs 7.3/10. If budget is your priority, PeterMD starts at $165/mo compared to Willow's $299/mo. Choose PeterMD if you want: budget-conscious users looking for the lowest monthly glp-1 cost. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither PeterMD nor Willow feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review